Is ASML Holding a Buy After Its Latest Earnings Report?

ASML reported Q2 revenue of €9.3B (≈$10.64B), up 6% YoY, and EPS of €7.59 (≈$8.68), also up 6%, beating both consensus (revenue €8.8B; EPS €6.90). Demand for its lithography systems drove margins higher, with gross margin up 100bps to 54%, and the company sold 91 total systems (+15% YoY). Management raised full-year sales to €44B at the midpoint and increased 2027 production capacity by 30% (and is considering another 30% for 2028), while Q3 guidance calls for €11B–€12B revenue and gross margin rising to 55%–57%.

Analysis

This print strengthens the case that the AI spend cycle is still upstream of peak, but the cleaner read is relative-value: ASML is the toll collector on leading-edge capacity, so the incremental winner is not just the stock itself but any foundry/customer that can still justify capex without destroying returns. The flip side is that higher utilization and a longer equipment backlog tighten the bottleneck for everyone else in the chain, which can compress margins at customers before it shows up in end-demand. For broad semis, the signal is supportive but not uniformly bullish; it argues for owning the scarcity layer over the beta layer.

The near-term catalyst is not another quarter of beat-and-raise so much as whether customers validate the longer-dated capacity build with deposits and order timing over the next 1-3 months. If that data holds, ASML’s valuation can stay elevated because the market will pay up for visibility and monopoly-like pricing power. The main falsifier is any pause in advanced-node capex or a commentary shift toward digestion; that would matter more than a modest miss on next quarter’s revenue because the stock is already priced for durable acceleration.

Contrarianly, the market may be underestimating how much of the AI trade has become a balance-sheet trade: everyone wants the chips, but only a few names can fund the equipment cycle without stress. That makes ASML structurally better than the average AI beneficiary, but it also means the easiest money may already be in the rerating. If the cycle keeps extending, ASML deserves a premium; if AI demand merely normalizes, the multiple can compress fast because the earnings base is still cyclically sensitive.

Key Decisions for Investors

• Long ASML on any 3-5% pullback over the next 1-2 sessions; target a 1-3 month hold into follow-on order/backlog commentary. Risk/reward: favorable if the market keeps rewarding visible EUV demand; exit if the post-earnings gap is fully retraced and guidance momentum stalls.
• Pair trade: long ASML / short SOXX for 1-3 months to isolate equipment scarcity versus broad semiconductor beta. This is the cleaner expression if you want AI exposure without paying for the full cyclicality of the index; thesis breaks if the whole semi complex re-rates on stronger macro AI capex.
• Trim or hedge high-beta AI semiconductor exposure in NVDA after strength and rotate a portion into ASML. ASML has the better visibility-to-valuation tradeoff here; NVDA remains the demand beneficiary, but ASML is the bottleneck supplier with more pricing power.
• Set a watch item on TSMC/Samsung/leading memory capex commentary over the next quarter. If those budgets flatten or extend less than expected, treat ASML as a sell-the-rally name; if they re-accelerate, the earnings revision cycle can continue for 6-18 months.